This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundCurrent evidence suggests that cardiovasculardisease (CVD) plays a role in the progression of chronic obstructive pulmonary disease (COPD). However, the relationship between CVD and the severity of COPD remains inadequately understood.
Hypertensive disorders of pregnancy as a risk factor for heart failure. BMI, body mass index; CV, cardiovascular; CVD, cardiovasculardisease; HELLP, haemolysis, elevated liver enzymes, low platelet count.
Background:Hypertension (HTN) is a major risk factor for cardiovasculardisease (CVD) and is the leading cause of morbidity and mortality globally, with a rise in prevalence in low and middle-income countries (LMIC). The proportion of people aware of their HTN diagnosis was 69%, but only 60% of them were on anti-hypertensives.
Hypertension, Volume 80, Issue 12 , Page 2581-2590, December 1, 2023. BACKGROUND:This study aimed to develop a risk-scoring model for hypertension among Africans.METHODS:In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. for the training set and 64.6% (95% CI, 61.0–68.0)
Association between body mass index (BMI) and clinical outcomes in PARADISE-MI. ( A ) Histogram for BMI (kg/m 2 ), ( B ) adverse events for BMI subgroups, and spline model curves for ( C ) the primary composite outcome and ( D ) cardiovascular (CV) death by BMI subgroups. 100 patient-years for BMI 40kg/m 2 ).
They get the diseases of ageing about 20 to 25 years later than everyone else. It’s not that they don’t get cardiovasculardisease, cancer or dementia; they just get it way later than everyone else. Most adults, healthy centenarians included, will die from one of three things: CardiovascularDisease.
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5
The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovasculardisease (CVD), the leading cause of death and disability in the United States.
In this study, we aim to analyze the MHO trends and outcomes with respect to Stroke.Methods:We queried the National Inpatient Sample (2016-2019) to identify Stroke hospitalizations in the elderly population (%E2%89%A565 years) with vs without MHO by using ICD-10 codes after excluding patients with Hypertension, analyze, and Diabetes Mellitus.
Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension. It became the first approved drug for chronic weight management in adults with obesity since 2014.
A, Normal axillary lymph nodes measuring milla1cf Fri, 05/10/2024 - 08:12 May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting , fat-enlarged axillary nodes on screening mammograms can predict high cardiovasculardisease (CVD) risk, Type 2 diabetes (T2DM), and hypertension (HTN).
Background:Racial disparities have been well described in cardiovasculardisease. Stroke, Volume 56, Issue Suppl_1 , Page AWP294-AWP294, February 1, 2025. Patients were categorized into two groups, one with Black or African American and another with White race patients. Both groups were followed for 12 months.
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.
But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovasculardiseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.
COSMOS tested a cocoa extract supplement and a multivitamin-mineral supplement against one another and a placebo for reducing the risk of cardiovasculardisease and cancer. This hypothesis was studied in a randomized controlled trial known as the COcoa Supplement and Multivitamin Outcomes Study or COSMOS.
BackgroundCardiovascular disease(CVD) remains a significant global challenge. Asthma, which is characterized by airway hyperresponsiveness and reversible and limited airflow, plays an important role in cardiovasculardiseases. Patients with asthma should be monitored for CVD, including stroke and congestive heart failure.
Case Study: A Common Clinical Scenario This case study highlights the complex relationship between metabolic disease and liver health. One of the most significant risks for patients with both T2D and MASH is cardiovasculardisease (CVD), which is the leading cause of death in this population.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content